Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials

NCT05439941 is registered in ClinicalTrials.gov with Evelo Biosciences, Inc. as lead sponsor.

NCT NCT05439941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials
Lead sponsor
Evelo Biosciences, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 6, 2022
Completion date
June 7, 2023
Enrollment
287 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis